2002-2003
The following is a description of a study from one of the many researchers that our organization has funded.
Immunomodulatory CD28 Peptides in the treatment of Collagen-Induced Arthritis
Mythily Srinivasan, M.D.S., Ph.D.
Ohio State University
Columbus, Ohio
The goals of Dr. Srinivasan’s study are to explore the therapeutic advantages of preventing and improving arthritis through treatment with a synthetic peptide. They will use a mouse model that shares many clinical features of human rheumatoid arthritis and serves as a pre-clinical testing ground for RA.
You may return to the list of research that we have funded.
